These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36870915)

  • 1. Using the planetary health framework to assess phytotherapeutic agents in the treatment of benign prostatic hyperplasia.
    Faure N
    Prog Urol; 2023 May; 33(6):285-286. PubMed ID: 36870915
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.
    Elterman DS; Lawrentschuk N; Guns E; Hersey K; Adomat H; Wood CA; Fleshner N
    J Urol; 2010 May; 183(5):2085-9. PubMed ID: 20303529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alpha-blockers or phytotherapy as first-line treatment of LUTS/BPH in general medicine: The PERSAT non-interventional study].
    de la Taille A; Bardin L; Castagné C; Auges M; Capronnier O; Chalret du Rieu Q
    Prog Urol; 2020 Sep; 30(10):522-531. PubMed ID: 32753297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytotherapeutic Agents for Benign Prostatic Hyperplasia: An Overview.
    Sharma M; Chadha R; Dhingra N
    Mini Rev Med Chem; 2017; 17(14):1346-1363. PubMed ID: 27337973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytotherapy for benign prostatic hyperplasia.
    Wilt TJ; Ishani A; Rutks I; MacDonald R
    Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytotherapeutic agents in the treatment of benign prostatic hyperplasia.
    Dreikorn K
    Curr Urol Rep; 2000 Aug; 1(2):103-9. PubMed ID: 12084323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future concepts in the medical therapy of benign prostatic hyperplasia.
    Cuellar DC; Kyprianou N
    Curr Opin Urol; 2001 Jan; 11(1):27-33. PubMed ID: 11148743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytotherapy in urology. Current scientific evidence of its application in benign prostatic hyperplasia and prostate adenocarcinoma.
    Manasanch J; Conesa A
    Actas Urol Esp; 2014; 38(1):66-7. PubMed ID: 24119632
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to "Phytotherapy in urology. Current scientific evidence of its application in benign prostatic hyperplasia and prostate adenocarcinoma".
    Morán E; Budía A
    Actas Urol Esp; 2014; 38(1):67-8. PubMed ID: 24119634
    [No Abstract]   [Full Text] [Related]  

  • 10. An overview of phytotherapeutic approaches for the treatment of benign prostatic hyperplasia.
    Aggarwal S; Verma A; Shukla R; Batra S; Bhardwaj TR; Kumar M
    Mini Rev Med Chem; 2014; 14(3):257-70. PubMed ID: 24456273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectivity of phytotherapeutic agent prostavit for the treatment of benign prostate hyperplasia].
    Matjosaitis A; Radavicius A
    Medicina (Kaunas); 2002; 38 Suppl 1():59-62. PubMed ID: 12556637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Up-to-date on the treatment of benign prostatic hyperplasia. Which adenoma to treat and how to do it?].
    Lahlaidi K; Ariane MM; Fontaine E
    Rev Med Interne; 2014 Mar; 35(3):189-95. PubMed ID: 24262410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytotherapy in the management of benign prostatic hyperplasia.
    Lowe FC
    Urology; 2001 Dec; 58(6 Suppl 1):71-6; discussion 76-7. PubMed ID: 11750257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phytotherapy in urology. Current scientific evidence of its application in benign prostatic hyperplasia and prostate adenocarcinoma].
    Morán E; Budía A; Broseta E; Boronat F
    Actas Urol Esp; 2013 Feb; 37(2):114-9. PubMed ID: 23058996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of phytotherapy on utility scores for 5 benign prostatic hyperplasia/lower urinary tract symptoms health states.
    Dedhia RC; Calhoun E; McVary KT
    J Urol; 2008 Jan; 179(1):220-5. PubMed ID: 18001791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytotherapy for benign prostatic hyperplasia.
    Gerber GS
    Curr Urol Rep; 2002 Aug; 3(4):285-91. PubMed ID: 12149159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a phytotherapeutic agent, Eviprostat®, on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitis.
    Sugimoto M; Oka M; Tsunemori H; Yamashita M; Kakehi Y
    Prostate; 2011 Mar; 71(4):438-44. PubMed ID: 21254154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Status of phytotherapeutic drugs in treatment of benign prostatic hyperplasia].
    Dreikorn K; Schönhöfer PS
    Urologe A; 1995 Mar; 34(2):119-29. PubMed ID: 7538709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What do we know about phytotherapy of benign prostatic hyperplasia?
    Allkanjari O; Vitalone A
    Life Sci; 2015 Apr; 126():42-56. PubMed ID: 25703069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cernilton for benign prostatic hyperplasia.
    Wilt T; Mac Donald R; Ishani A; Rutks I; Stark G
    Cochrane Database Syst Rev; 2000; (2):CD001042. PubMed ID: 10796739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.